DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:DMP • DE000A2GS5D8

34.9 EUR
-0.2 (-0.57%)
Last: Feb 3, 2026, 09:57 AM
Fundamental Rating

5

Overall DMP gets a fundamental rating of 5 out of 10. We evaluated DMP against 55 industry peers in the Pharmaceuticals industry. Both the profitability and the financial health of DMP get a neutral evaluation. Nothing too spectacular is happening here. DMP has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • DMP had positive earnings in the past year.
  • DMP had a positive operating cash flow in the past year.
  • In the past 5 years DMP has always been profitable.
  • In the past 5 years DMP always reported a positive cash flow from operatings.
DMP.DE Yearly Net Income VS EBIT VS OCF VS FCFDMP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

  • DMP's Return On Assets of 5.48% is in line compared to the rest of the industry. DMP outperforms 45.45% of its industry peers.
  • DMP has a Return On Equity (17.87%) which is in line with its industry peers.
  • DMP has a Return On Invested Capital of 7.26%. This is comparable to the rest of the industry: DMP outperforms 41.82% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for DMP is below the industry average of 14.23%.
Industry RankSector Rank
ROA 5.48%
ROE 17.87%
ROIC 7.26%
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
DMP.DE Yearly ROA, ROE, ROICDMP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • DMP has a worse Profit Margin (10.00%) than 60.00% of its industry peers.
  • DMP's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 18.70%, DMP is in line with its industry, outperforming 47.27% of the companies in the same industry.
  • DMP's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 66.57%, DMP is doing worse than 65.45% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DMP has grown nicely.
Industry RankSector Rank
OM 18.7%
PM (TTM) 10%
GM 66.57%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
DMP.DE Yearly Profit, Operating, Gross MarginsDMP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DMP is creating some value.
  • Compared to 1 year ago, DMP has about the same amount of shares outstanding.
  • Compared to 5 years ago, DMP has about the same amount of shares outstanding.
  • DMP has a worse debt/assets ratio than last year.
DMP.DE Yearly Shares OutstandingDMP.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
DMP.DE Yearly Total Debt VS Total AssetsDMP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.18 indicates that DMP is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.18, DMP is doing worse than 63.64% of the companies in the same industry.
  • The Debt to FCF ratio of DMP is 6.15, which is on the high side as it means it would take DMP, 6.15 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of DMP (6.15) is comparable to the rest of the industry.
  • DMP has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.44, DMP is doing worse than 76.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 6.15
Altman-Z 2.18
ROIC/WACC1.09
WACC6.65%
DMP.DE Yearly LT Debt VS Equity VS FCFDMP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • DMP has a Current Ratio of 2.20. This indicates that DMP is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.20, DMP is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
  • A Quick Ratio of 1.04 indicates that DMP should not have too much problems paying its short term obligations.
  • DMP has a Quick ratio (1.04) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.04
DMP.DE Yearly Current Assets VS Current LiabilitesDMP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 28.01% over the past year.
  • DMP shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.07% yearly.
  • DMP shows a small growth in Revenue. In the last year, the Revenue has grown by 0.11%.
  • Measured over the past years, DMP shows a quite strong growth in Revenue. The Revenue has been growing by 11.00% on average per year.
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%

3.2 Future

  • DMP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.68% yearly.
  • The Revenue is expected to grow by 2.79% on average over the next years.
EPS Next Y11.31%
EPS Next 2Y10.93%
EPS Next 3Y10.12%
EPS Next 5Y14.68%
Revenue Next Year-0.83%
Revenue Next 2Y1.53%
Revenue Next 3Y2.28%
Revenue Next 5Y2.79%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DMP.DE Yearly Revenue VS EstimatesDMP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
DMP.DE Yearly EPS VS EstimatesDMP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 16.23, which indicates a correct valuation of DMP.
  • DMP's Price/Earnings ratio is a bit cheaper when compared to the industry. DMP is cheaper than 67.27% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.41, DMP is valued a bit cheaper.
  • DMP is valuated correctly with a Price/Forward Earnings ratio of 13.87.
  • 72.73% of the companies in the same industry are more expensive than DMP, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.64, DMP is valued a bit cheaper.
Industry RankSector Rank
PE 16.23
Fwd PE 13.87
DMP.DE Price Earnings VS Forward Price EarningsDMP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DMP indicates a somewhat cheap valuation: DMP is cheaper than 80.00% of the companies listed in the same industry.
  • 83.64% of the companies in the same industry are more expensive than DMP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.43
EV/EBITDA 9.09
DMP.DE Per share dataDMP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • DMP's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.44
PEG (5Y)2.01
EPS Next 2Y10.93%
EPS Next 3Y10.12%

More info and screens

6

5. Dividend

5.1 Amount

  • DMP has a Yearly Dividend Yield of 2.55%.
  • Compared to an average industry Dividend Yield of 1.95, DMP pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.83, DMP pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.55%

5.2 History

  • The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
DMP.DE Yearly Dividends per shareDMP.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • 41.76% of the earnings are spent on dividend by DMP. This is a bit on the high side, but may be sustainable.
  • The dividend of DMP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP41.76%
EPS Next 2Y10.93%
EPS Next 3Y10.12%
DMP.DE Yearly Income VS Free CF VS DividendDMP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DMP.DE Dividend Payout.DMP.DE Dividend Payout, showing the Payout Ratio.DMP.DE Dividend Payout.PayoutRetained Earnings

More info and screens

DERMAPHARM HOLDING SE

FRA:DMP (2/3/2026, 9:57:24 AM)

34.9

-0.2 (-0.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-13
Earnings (Next)03-17
Inst Owners11.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.88B
Revenue(TTM)1.16B
Net Income(TTM)116.03M
Analysts78.18
Price Target42.84 (22.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.55%
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP41.76%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.14%
EPS NY rev (3m)-1.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.25%
Valuation
Industry RankSector Rank
PE 16.23
Fwd PE 13.87
P/S 1.62
P/FCF 11.43
P/OCF 9.1
P/B 2.89
P/tB N/A
EV/EBITDA 9.09
EPS(TTM)2.15
EY6.16%
EPS(NY)2.52
Fwd EY7.21%
FCF(TTM)3.05
FCFY8.75%
OCF(TTM)3.84
OCFY10.99%
SpS21.55
BVpS12.06
TBVpS-7.73
PEG (NY)1.44
PEG (5Y)2.01
Graham Number24.15
Profitability
Industry RankSector Rank
ROA 5.48%
ROE 17.87%
ROCE 11.89%
ROIC 7.26%
ROICexc 7.91%
ROICexgc 21.74%
OM 18.7%
PM (TTM) 10%
GM 66.57%
FCFM 14.17%
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexgc growth 3Y-9.69%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 6.15
Debt/EBITDA 3.09
Cap/Depr 49.31%
Cap/Sales 3.63%
Interest Coverage 4.01
Cash Conversion 68.3%
Profit Quality 141.71%
Current Ratio 2.2
Quick Ratio 1.04
Altman-Z 2.18
F-Score7
WACC6.65%
ROIC/WACC1.09
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
EPS Next Y11.31%
EPS Next 2Y10.93%
EPS Next 3Y10.12%
EPS Next 5Y14.68%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%
Revenue Next Year-0.83%
Revenue Next 2Y1.53%
Revenue Next 3Y2.28%
Revenue Next 5Y2.79%
EBIT growth 1Y5.29%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.22%
EBIT Next 3Y19.63%
EBIT Next 5Y7.42%
FCF growth 1Y-31.18%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-25.65%
OCF growth 3Y-7%
OCF growth 5Y14.89%

DERMAPHARM HOLDING SE / DMP.DE FAQ

What is the fundamental rating for DMP stock?

ChartMill assigns a fundamental rating of 5 / 10 to DMP.DE.


Can you provide the valuation status for DERMAPHARM HOLDING SE?

ChartMill assigns a valuation rating of 5 / 10 to DERMAPHARM HOLDING SE (DMP.DE). This can be considered as Fairly Valued.


How profitable is DERMAPHARM HOLDING SE (DMP.DE) stock?

DERMAPHARM HOLDING SE (DMP.DE) has a profitability rating of 4 / 10.


What are the PE and PB ratios of DERMAPHARM HOLDING SE (DMP.DE) stock?

The Price/Earnings (PE) ratio for DERMAPHARM HOLDING SE (DMP.DE) is 16.23 and the Price/Book (PB) ratio is 2.89.


Can you provide the expected EPS growth for DMP stock?

The Earnings per Share (EPS) of DERMAPHARM HOLDING SE (DMP.DE) is expected to grow by 11.31% in the next year.